Clinical Trial Update: Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR [NA]

View source ↗

Summary

Clinical trial update assessing the safety and effectiveness of the EMBLOK Embolic Protection System during transcatheter aortic valve replacement, with no cere…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Insufficiency
• Aortic Valve Regurgitation
• Aortic Valve Stenosis

Drugs mentioned

• EMBLOK EPS

Snippet

Sponsor: Emblok, Inc. | Conditions: AORTIC VALVE DISEASES, Aortic Valve Stenosis and/or Insufficiency | NA | Status: NOT_YET_RECRUITING